Drosophila melanogaster: A platform for anticancer drug discovery and personalized therapies
Cancer is a complex disease whereby multiple genetic aberrations, epigenetic modifications, metabolic reprogramming, and the microenvironment contribute to the development of a tumor. In the traditional anticancer drug discovery pipeline, drug candidates are usually screened in vitro using two-dimen...
Main Authors: | Chamoné Munnik, Malungi P. Xaba, Sibusiso T. Malindisa, Bonnie L. Russell, Selisha A. Sooklal |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2022.949241/full |
Similar Items
-
The genome of drosophila melanogaster /
by: 385799 Lindsley, Dan L., et al.
Published: (1992) -
Arborine, a larval growth inhibitor against Drosophila melanogaster
by: 330990 Farediah Ahmad, et al.
Published: (1991) -
Using Drosophila melanogaster as a suitable platform for drug discovery from natural products in inflammatory bowel disease
by: Minghui Xiu, et al.
Published: (2022-12-01) -
Sleep-control circuits in Drosophila melanogaster
by: Garmendia Sanchez, L
Published: (2021) -
Specific Identification Method based on PCR for Drosophila melanogaster
by: Yousef Naserzadeh, et al.
Published: (2020-12-01)